Shanghai, China

Fang Nan

This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fang Nan. Retrieved from https://idiyas.com/inventor/fang-nan-i5fy4w3c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Fang Nan in the Field of Medicine

Introduction

Fang Nan is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly in the treatment of systemic lupus erythematosus. His innovative approach utilizes circular RNA, showcasing the potential of genetic materials in therapeutic applications.

Latest Patents

Fang Nan holds a patent for the "Application of circular RNA in preparing drug for treating systemic lupus erythematosus." This invention provides the use of a circular RNA with an incomplete double-stranded structure of 16 bp-33 bp in length, along with a promoting agent, in the preparation of a medicament for treating this autoimmune disease. This patent highlights the cutting-edge research being conducted in the realm of genetic therapies.

Career Highlights

Fang Nan is affiliated with the Chinese Academy of Sciences, where he engages in groundbreaking research. His work is pivotal in advancing the understanding and treatment of complex diseases, contributing to the scientific community's knowledge base.

Collaborations

Fang Nan collaborates with esteemed colleagues, including Lingling Chen and Li Yang. Their combined expertise fosters an environment of innovation and discovery, enhancing the potential for future breakthroughs in medical science.

Conclusion

Fang Nan's contributions to the field of medicine through his innovative patent demonstrate the importance of research in developing new treatments. His work not only addresses critical health issues but also paves the way for future advancements in genetic therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…